PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1567182
PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1567182
Global anti-infective endotracheal tube market is estimated to be valued at USD 850 Mn in 2024 and is expected to reach USD 1,200 Mn by 2031, exhibiting a compound annual growth rate (CAGR) of 5% from 2024 to 2031.
Report Coverage | Report Details | ||
---|---|---|---|
Base Year: | 2023 | Market Size in 2024: | US$ 850 Mn |
Historical Data for: | 2019 to 2023 | Forecast Period: | 2024 to 2031 |
Forecast Period 2024 to 2031 CAGR: | 5.00% | 2031 Value Projection: | US$ 1,200 Mn |
Global anti-infective endotracheal tube market growth is driven by rising incidence of hospital acquired pneumonia (HAP). Anti-infective endotracheal tubes help prevent ventilator associated pneumonia, which affects millions of intubated patients worldwide each year and contributes substantially to patient morbidity, mortality and healthcare costs. These tubes have an antibacterial coating that reduces bacterial adhesion and biofilm formation in the lower respiratory tract, thus, helping curb the risk of pneumonia during ventilation. Their use in mechanically ventilated patients is becoming increasingly important as antibiotic resistance grows and standards of care evolve to mitigate an important cause of preventable harm.
Global anti-infective endotracheal tube market growth is primarily driven by rising demand for technologies and solutions that enhance patient safety, reduce complications, and lower healthcare costs associated with hospital stays. Growing geriatric population who are more prone to critical illness can also drive the market growth. However, high costs associated with these specialty tubes compared to conventional tubes can hamper the market growth. Increasing investments by governments and payers to curb hospital acquired infections offer numerous lucrative growth opportunities. Ongoing R&D aimed at developing more effective coatings and designs can expand commercial scope for existing players.
This report provides in-depth analysis of the global anti-infective endotracheal tube market, and provides market size (USD Million) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global anti-infective endotracheal tube market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Teleflex, Medtronic, Micro-Tech (Nanjing), Rochester Medical Corporation, Intersurgical, Fuji System
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global anti-infective endotracheal tube market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global anti-infective endotracheal tube market